Related Experiment Videos

Dominant negative MORT1/FADD rescues mice from CD95 and TNF-induced liver failure

Marcus Schuchmann1, Eugene E Varfolomeev, Frank Hermann

  • 1I. Medical Department, University of Mainz, Germany. schuchm@mail.uni-mainz.de

Hepatology (Baltimore, Md.)
|December 25, 2002
PubMed

Insights

MORT1/FADD is crucial for liver injury caused by Fas and TNF signaling. Blocking this molecule protected mice from liver failure, highlighting its therapeutic potential for liver disease.

Area of Science:

  • Hepatology
  • Immunology
  • Molecular Biology

Background:

  • Derangements in apoptosis contribute to liver disease.
  • Receptor-mediated apoptosis, particularly via CD95 and CD120a (TNF receptor superfamily), is key.
  • The adapter molecule MORT1/FADD mediates death signals by recruiting caspases.

Purpose of the Study:

  • To investigate the role of MORT1/FADD in hepatocyte apoptosis and Fas/TNF-mediated liver injury.
  • To determine if inhibiting MORT1/FADD can prevent liver failure.

Main Methods:

  • Generation of transgenic mice with liver-specific dominant-negative MORT1/FADD.
  • Induction of liver failure using anti-Fas antibody (Jo2) and TNF.
  • Assessment of survival rates and histological analysis of liver damage.

Main Results:

  • Transgenic mice were protected from anti-Fas antibody-induced liver failure.
  • Histology showed reduced inflammatory changes and hemorrhagic hepatitis in transgenic mice.
  • Transgenic mice also exhibited improved survival in a TNF-mediated liver failure model.

Conclusions:

  • MORT1/FADD is essential for Fas and TNF-induced hepatic injury.
  • Targeting MORT1/FADD presents a potential therapeutic strategy for liver diseases.
  • This study provides a model for investigating other causes of liver injury.

Related Concept Videos